tiprankstipranks
Marvel Biosciences Corp (TSE:MRVL)
TSXV:MRVL
Canadian Market
Holding TSE:MRVL?
Track your performance easily

Marvel Biosciences Corp (MRVL) Stock Price & Analysis

13 Followers

MRVL Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

15.01%84.99%
15.01% Insiders
― Other Institutional Investors
84.99% Public Companies and
Individual Investors

MRVL FAQ

What was Marvel Biosciences Corp’s price range in the past 12 months?
Marvel Biosciences Corp lowest stock price was C$0.06 and its highest was C$0.19 in the past 12 months.
    What is Marvel Biosciences Corp’s market cap?
    Currently, no data Available
    When is Marvel Biosciences Corp’s upcoming earnings report date?
    Marvel Biosciences Corp’s upcoming earnings report date is Dec 16, 2024 which is in 24 days.
      How were Marvel Biosciences Corp’s earnings last quarter?
      Currently, no data Available
      Is Marvel Biosciences Corp overvalued?
      According to Wall Street analysts Marvel Biosciences Corp’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Marvel Biosciences Corp pay dividends?
        Marvel Biosciences Corp does not currently pay dividends.
        What is Marvel Biosciences Corp’s EPS estimate?
        Marvel Biosciences Corp’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Marvel Biosciences Corp have?
        Marvel Biosciences Corp has 44,786,232 shares outstanding.
          What happened to Marvel Biosciences Corp’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Marvel Biosciences Corp?
          Currently, no hedge funds are holding shares in TSE:MRVL
          ---

          Company Description

          Marvel Biosciences Corp

          Alphanco Venture Corp is a capital pool company based in Canada. It proposes to identify and evaluate corporations, businesses or assets for acquisition and once identified and evaluated to negotiate an acquisition or participation subject to receipt of regulatory and shareholder approval, as applicable.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Revive Therapeutics
          Popular Stocks
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis